Bone histomorphometry of renal osteodystrophy in diabetic patients

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of Bone and Mineral Research

• Publication date

  1987-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jbmr.5650020609PMID 3455634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Haversian bone formation rates determined by a new method in a mastodon, and in human diabetes mellitus and osteoporosis

  2005cited by this paper
• Early deposition of aluminum in bone in diabetic patients on hemodialysis.

  1987cited by this paper
• Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy.

  1986cited by this paper
• Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays.

  1986cited by this paper
• Parathyroid hormone stimulates the proliferation of cells derived from human bone.

  1986cited by this paper
• Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure.

  1985cited by this paper
• In vitro model of aluminum-induced osteomalacia: Inhibition of hydroxyapatite formation and growth

  1984cited by this paper
• Parathyroid and bone response of the diabetic patient to uremia.

  1984cited by this paper
• Use of oral calcium loading to characterize the hypercalciuria of young insulin-dependent diabetics.

  1983cited by this paper
• Suppression of parathyroid hormone secretion by aluminum.

  1983cited by this paper
• Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia.

  1983cited by this paper
• Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects.

  1983cited by this paper
• In vitro effects of aluminum on bone phosphatases: A possible interaction with bPTH and vitamin D3 metabolites

  1982cited by this paper
• Histological quantitation of aluminum in iliac bone from patients with renal failure.

  1982cited by this paper
• Calcium homeostasis in chronic streptozotocin-induced diabetes mellitus in the rat.

  1982cited by this paper
• Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic.

  1981cited by this paper
• Osteopenia in juvenile diabetes

  1981cited by this paper
• Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism.

  1981cited by this paper
• Hypoparathyroidism in diabetes mellitus.

  1981cited by this paper
• Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis.

  1981cited by this paper
• Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy.

  1981cited by this paper
• Do parathyroid hormone and 1,25-dithydroxyvitamin D modulate bone formation in uremia?

  1980cited by this paper
• Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness.

  1980cited by this paper
• Osteopenia in insulin treated diabetes mellitus

  1978cited by this paper
• Decreased cortical thickness & osteopenia in children with diabetes mellitus.

  1977cited by this paper
• Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes.

  1976cited by this paper
• Serum immunoreactive parathyroid hormone and 25-hydroxyvitamin D in patients with uremic bone diseases.

  1975cited by this paper
• Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.

  1975cited by this paper
• Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.

  1975cited by this paper
• Quantitative histological studies on the pathogenesis of uremic bone disease.

  1974cited by this paper
• Azotaemic renal osteodystrophy: a quantitative study on iliac bone

  1973cited by this paper
• Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.

  1970cited by this paper

• Fibroblast growth factor 23 as a risk factor for incident diabetes

  2025cites this paper
• Study on the Effect of Low Calcium Dialysate on Biochemical Profile of Adynamic Bone Disease in Patients on Maintenance Hemodialysis

  2023cites this paper
• Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony

  2020cites this paper
• Актуальні проблеми лікування хворих на хронічне обструктивне захворювання легень

  2019cites this paper
• The Importance of Biologically Active Vitamin D for Mineralization by Osteocytes After Parathyroidectomy for Renal Hyperparathyroidism

  2019cites this paper
• Evaluation of prevalence, biochemical profile, and drugs associated with chronic kidney disease-mineral and bone disorder in 11 dialysis centers

  2018cites this paper
• Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis

  2018cites this paper
• Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis

  2018cites this paper
• Interrelationship Between Periapical Lesion and Systemic Metabolic Disorders.

  2016cites this paper
• Original Full Length Article 22-Oxacalcitriol attenuates bone loss in nonobese type 2 diabetes

  2015cites this paper
• 22-Oxacalcitriol attenuates bone loss in nonobese type 2 diabetes.

  2015cites this paper
• Parathyroid hormone and 25(OH) vitamin D levels in Cameroonian patients with Chronic Kidney Disease: A comparison of patients with and without diabetes

  2014cites this paper
• Drug Therapy Targets for Diabetic Nephropathy: An Overview

  2013cites this paper
• Diabetes, Biochemical Markers of Bone Turnover, Diabetes Control, and Bone

  2012cites this paper
• Vitamin D and Stage 5 Chronic Kidney Disease: A New Paradigm?

  2012influential citation
• Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients.

  2012cites this paper
• Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes.

  2012cites this paper
• Earlier Onset and Greater Severity of Disordered Mineral Metabolism in Diabetic Patients With Chronic Kidney Disease

  2012influential citation
• CIRCULATING SCLEROSTIN LEVELS AND BONE TURNOVER IN TYPE 1 AND TYPE 2 DIABETES

  2011cites this paper
• [Analysis of variability in determining intact parathyroid hormone (iPTH) according to the method used to process the sample].

  2009cites this paper
• Adynamic bone disease—bone and beyond

  2008cites this paper
• Adynamic bone in patients with chronic kidney disease.

  2008cites this paper
• Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy.

  2007influential citation
• Diabetic bone disease

  2007cites this paper
• Adynamic Bone Revisited: Is there Progress?

  2006cites this paper
• Effect of kidney transplantation on bone

  2006cites this paper
• Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome.

  2005cites this paper
• Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.

  2005cites this paper
• Age-related decline in serum parathyroid hormone in maintenance hemodialysis patients is independent of inflammation and dietary nutrient intake.

  2004cites this paper
• Long-term fracture risk following renal transplantation: a population-based study

  2004cites this paper
• Modulation of osteoblast activity by serum from diabetic and non-diabetic patients on hemodialysis: a three-dimensional culture study.

  2004cites this paper
• Bone metabolism and disease in chronic kidney disease

  2003cites this paper
• Metabolic aspects on diabetic nephropathy

  2003cites this paper
• Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.

  2003cites this paper
• Factors affecting bone mineral density in hemodialysis patients with diabetic nephropathy.

  2003cites this paper
• Renal osteodystrophy

  2002cites this paper
• Diabetes mellitus a risk for osteoporosis?

  2001cites this paper
• Adynamic renal osteodystrophy: is there a problem?

  2001influential citation
• Calcium, phosphate and renal osteodystrophy

  2000cites this paper
• Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial.

  2000cites this paper
• Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure.

  1999cites this paper
• Analysis of fracture prevalence in kidney-pancreas allograft recipients.

  1998cites this paper
• Renal Osteodystrophy: New Insights in Pathophysiology and Treatment Modalities with Special Emphasis on the Insulin-Like Growth Factor System

  1998cites this paper
• Bone Mass and Bone Loss in Secondary Osteoporosis

  1998cites this paper
• Is there a lesser hyperparathyroidism in diabetic patients with chronic renal failure?

  1998cites this paper
• Secondary osteoporosis

  1998cites this paper
• Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies.

  1996cites this paper
• Renal osteodystrophy in rats with reduced renal mass.

  1996cites this paper
• Low Turnover Bone Disease in Dialysis Patients

  1996cites this paper
• Risk factors for renal osteodystrophy: A multivariant analysis

  1995cites this paper
• Effect of treatment of hemodialysis patients with nifedipine on metabolism and function of polymorphonuclear leukocytes.

  1995cites this paper
• Symptomatic hypercalcemia in a diabetic patient undergoing continuous ambulatory peritoneal dialysis: value of bone biopsy in the diagnosis and management.

  1995cites this paper
• Aplastic Osteodystrophy

  1994cites this paper
• Racial differences in bone turnover rate and hyperparathyroidism in hemodialysis patients

  1994cites this paper
• Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis.

  1994cites this paper
• The National Kidney Foundation 1994 Annual Scientific Meeting

  1994cites this paper
• The spectrum of bone disease in end-stage renal failure--an evolving disorder.

  1993cites this paper
• Bone histomorphometry in chronic renal failure

  1993cites this paper
• The role of aluminum in renal osteodystrophy.

  1993cites this paper
• Renal osteodystrophy in diabetic patients.

  1993cites this paper
• Musculoskeletal complications after renal transplantation: pathogenesis and treatment.

  1992cites this paper
• Deferoxamine test and PTH serum levels are useful not to recognize but to exclude aluminum-related bone disease.

  1992cites this paper
• Identification of a low molecular weight inhibitor of osteoblast mitogenesis in uremic plasma.

  1991cites this paper
• Aluminum Bone Disease in Chronic Renal Failure

  1990cites this paper
• Effects of high concentrations of glucose on PTH secretion in parathyroid cells.

  1990cites this paper
• Risk factors for aluminum toxicity and its prevention

  1990cites this paper